Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

QT variability.

Ronald D Berger1

  • 1Department of Medicine, John Hopkins University School of Medicine, Baltimore, MD 21287, USA. rberger@jhmi.edu

Journal of Electrocardiology
|January 13, 2004
PubMed
Summary
This summary is machine-generated.

Temporal lability in ventricular repolarization, measured by QT variability index (QTVI), indicates a higher risk of dangerous ventricular arrhythmias. This reproducible measure is elevated in cardiomyopathy patients and predicts cardiac arrest risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digital Twin-Guided Ablation for Ventricular Tachycardia.

The New England journal of medicine·2026
Same author

Assessment of Intraprocedural Automated Arrhythmia Origin Localization System for Localizing Pacing Sites in 3D Space.

JACC. Clinical electrophysiology·2025
Same author

Lipomatous Metaplasia Facilitates Ventricular Tachycardia in Patients With Nonischemic Cardiomyopathy.

JACC. Clinical electrophysiology·2024
Same author

Lipomatous Metaplasia Is Associated With Ventricular Tachycardia Recurrence Following Ablation in Patients With Nonischemic Cardiomyopathy.

JACC. Clinical electrophysiology·2024
Same author

Pulmonary Vein Isolation With or Without Left Atrial Appendage Ligation in Atrial Fibrillation: The aMAZE Randomized Clinical Trial.

JAMA·2024
Same author

Conduction Velocity Dispersion Predicts Postinfarct Ventricular Tachycardia Circuit Sites and Associates With Lipomatous Metaplasia.

JACC. Clinical electrophysiology·2023
Same journal

Feasibility and efficacy of left bundle branch area pacing guided by modified chest lead 1.

Journal of electrocardiology·2026
Same journal

Spatial proximity or vector orientation? Re-evaluating ECG interpretation in anterior myocardial infarction using cardiac magnetic resonance.

Journal of electrocardiology·2026
Same journal

Pacing spikes without visible QRS complexes: Failure to capture?

Journal of electrocardiology·2026
Same journal

Rethinking prediction of sudden cardiac arrest: The role of electrocardiography in forecasting low-incidence, high-consequence events.

Journal of electrocardiology·2026
Same journal

New subtle anterior Q-wave and LAD occlusion.

Journal of electrocardiology·2026
Same journal

Monday-to-Friday workweek trajectory of ventricular repolarization and heart rate variability in apparently stable adults: A repeated-measures study.

Journal of electrocardiology·2026
See all related articles

Area of Science:

  • Cardiology
  • Electrophysiology
  • Biomedical Engineering

Background:

  • Ventricular repolarization lability is a potential marker for malignant ventricular arrhythmias.
  • Assessing this lability in the surface electrocardiogram requires precise measurement of beat-to-beat QT interval changes.

Purpose of the Study:

  • To develop and validate an automated algorithm for quantifying QT variability.
  • To investigate the association between QT variability and the risk of malignant ventricular arrhythmias.

Main Methods:

  • Developed an automated template-matching algorithm to measure beat-to-beat QT interval variations.
  • Calculated a QT variability index (QTVI) relative to heart rate variability.
  • Validated QTVI in patients with dilated cardiomyopathy, hypertrophic cardiomyopathy, and those undergoing electrophysiologic testing.

Related Experiment Videos

Main Results:

  • QTVI is a reproducible measure.
  • QTVI was significantly elevated in patients with ischemic and nonischemic dilated cardiomyopathy compared to controls.
  • QTVI was also elevated in patients with hypertrophic cardiomyopathy due to beta-myosin heavy-chain mutations.
  • QTVI outperformed electrophysiologic testing and other risk stratifiers in identifying patients with prior cardiac arrest.

Conclusions:

  • QT variability, quantified by QTVI, serves as a significant marker of ventricular electrical disease.
  • Elevated QTVI is associated with an increased risk of life-threatening ventricular arrhythmias.
  • QTVI demonstrates clinical utility in risk stratification for sudden cardiac death.